We help medical customers manage component obsolescence and supply changes without losing control of the approved PCBA configuration. Our ISO 13485 quality-management foundation supports documented review, authorization, production release and traceability for applicable component changes.
You receive early visibility into BOM risk, a structured comparison for proposed alternatives and records showing which approved component configuration entered production. We do not install a substitute only because it is available.
Medical Component-Change Evidence
| Change concern | Our control | Evidence |
|---|---|---|
| Incomplete part identity | Confirm manufacturer, full MPN and approval status | Released BOM |
| Obsolescence or shortage | Identify affected production and available options | Risk notice |
| Proposed alternative | Compare electrical, mechanical and manufacturing differences | Change proposal for customer review |
| Validation requirement | Define first article, inspection, test or customer activity | Approved evidence plan |
| Production release | Update controlled BOM and affected files | Revision and work-order link |
We Establish a Complete Purchasing Baseline
Our BOM review checks manufacturer part numbers, approved manufacturers, package, quantity, source restrictions and substitution status. Ambiguous descriptions are returned before procurement.
The approved BOM remains connected to the medical PCBA part and revision. Purchasing cannot replace this authority with distributor descriptions or informal email notes.
We Identify Supply Risk Before It Stops Production
We prioritize processors, memories, sensors, analog devices, power parts, programmed components, special connectors and single-source items. Lifecycle notices, extended lead time and source changes are reviewed for their effect on forecast and service needs.
Early review gives your team time to consider lifetime buy, second-source qualification, redesign or schedule changes.
Alternative Parts Receive a Documented Comparison
We compare function, ratings, pinout, package, dimensions, terminal finish, temperature grade, compliance, lifecycle and source. We also review moisture sensitivity, placement, soldering, inspection, programming and test effects.
The comparison does not approve the medical-device change. It gives your engineering and quality teams the manufacturing information needed for the required decision.
Customer Authorization Controls the Change
Proposed alternatives remain outside the released BOM until the agreed approval is received. The customer determines design, regulatory, risk-management and validation needs for the medical device.
After approval, we update the controlled BOM and affected assembly, inspection, programming or test information. Temporary approvals retain their defined boundary.
Validation Evidence Matches the Change Risk
A minor sourcing change and a functionally significant semiconductor change do not require the same evidence. The agreed plan may include first article, dimensional review, AOI, X-ray, electrical test, programming verification, FCT or customer-level validation.
We execute and record the manufacturing evidence assigned to us. Product safety and regulatory validation remain with the responsible device organization unless explicitly contracted and defined.
Traceability Preserves the Installed Component Identity
Where required, available manufacturer, source, lot, date-code or UID information can be connected to the work order or serialized product. The required identifiers and retention are agreed before procurement.
This helps your team identify affected production if a manufacturer notice, lot concern or complaint appears later.
Repeat Orders Return to the Approved Baseline
Before purchasing, we compare the requested revision with the released BOM and review relevant lifecycle conditions. Expired deviations or unapproved alternatives do not automatically carry forward.
Your team receives any new supply question before material commitment.
Why Medical Customers Use Our Change-Control Process
We combine supply-chain visibility with controlled product configuration. You retain authority over device changes while receiving manufacturing analysis and traceable production evidence.
This supports continuity without allowing a shortage to bypass engineering and quality review.
Send Your Medical PCBA BOM for Review
Send complete manufacturer part numbers, approved manufacturers, forecast, expected service life, source restrictions, traceability needs, validation requirements and change-approval process to sales@ebestpcba.com.
We will return identity gaps, lifecycle risks, proposed review priorities and evidence needed for any alternative.
How to Start a Component Change Review With Us
Provide your released BOM, approved manufacturer list, demand forecast and qualification restrictions. We will separate purchasing alternatives from changes that affect fit, form, function or validated performance. Your engineering team receives the proposed part, supporting data and the approval point before we change the controlled production package for the medical PCBA.
